Another recently developed approach to tackle challenging cancer types is based on connecting the chemotherapeutic agents with the peptide ligands which show a high affinity for receptors overexpressed in a tumor tissue, such as the gonadotropin releasing hormone receptor (GnRH-R). Here, GNRHR is linked to neoplasm.